[Arteriovenous extracorporeal membrane oxygenation (ECMO). A therapeutic option for fulminant pulmonary embolism].
According to the guidelines of the European (2008) and German Societies of Cardiology (2009) thrombolysis is recommended for patients with pulmonary embolisms presenting with cardiogenic shock (recommendation level I, evidence level A). If there are contraindications or thrombolysis is not successful surgical embolectomy should be considered (recommendation level I, evidence level C). Additional options are catheter-based therapies in the proximal pulmonary artery (recommendation level IIb, evidence level C). The use of arteriovenous extracorporeal membrane oxygenation ( ECMO) was not included in these  guidelines. A literature search in PubMed resulted in some case reports of the successful use of arteriovenous ECMO for resuscitation in patients with severe pulmonary embolisms following failed thrombolysis. In this article we present the case report of a patient who developed fulminant pulmonary embolism immediately after surgery. The patient was still in cardiogenic shock despite thrombolysis but the condition was stable following implementation of an arteriovenous ECMO. Acute heart failure and hypoxemia of all organs are the main symptoms of massive pulmonary embolisms. The use of arteriovenous ECMO represents a therapeutic option for life-threatening pulmonary embolism. A decisive factor for success is immediate diagnosis and rapid implementation of the system.
Chirurgische Universitätsklinik und Poliklinik, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, Bochum, Germany. justyna.swol@bergmannsheil.de
J
J
Swol
D
D
Buchwald
A
A
Ewers
T A
TA
Schildhauer
D000328:Adult; D004452:Echocardiography; D017128:Embolectomy; D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D008297:Male; D009104:Multiple Trauma / Q000601:surgery; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000628:therapy*; D012151:Resuscitation; D012770:Shock, Cardiogenic / Q000628:therapy; D015912:Thrombolytic Therapy; D017211:Treatment Failure